KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Exact Sciences (EXAS) Leases (2016 - 2025)

Exact Sciences (EXAS) has disclosed Leases for 16 consecutive years, with $122.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 4.57% to $122.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $122.3 million, a 4.57% increase, with the full-year FY2025 number at $122.3 million, up 4.57% from a year prior.
  • Leases was $122.3 million for Q4 2025 at Exact Sciences, up from $121.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $175.9 million in Q3 2022 to a low of $9.5 million in Q2 2022.
  • A 5-year average of $127.7 million and a median of $142.9 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: plummeted 94.31% in 2022, then soared 489.25% in 2025.
  • Exact Sciences' Leases stood at $174.2 million in 2021, then dropped by 4.13% to $167.0 million in 2022, then dropped by 13.95% to $143.7 million in 2023, then fell by 18.62% to $117.0 million in 2024, then increased by 4.57% to $122.3 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Leases are $122.3 million (Q4 2025), $121.1 million (Q3 2025), and $126.1 million (Q2 2025).